SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-110612
Filing Date
2020-04-17
Accepted
2020-04-17 16:02:53
Documents
4
Effectiveness Date
2020-04-17

Document Format Files

Seq Description Document Type Size
1 S-8 d895064ds8.htm S-8 82935
2 EX-5.1 d895064dex51.htm EX-5.1 7848
3 EX-23.1 d895064dex231.htm EX-23.1 1537
4 GRAPHIC g895064snap0001.jpg GRAPHIC 3006
  Complete submission text file 0001193125-20-110612.txt   97689
Mailing Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421 617-513-8774
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-237732 | Film No.: 20799685
SIC: 2834 Pharmaceutical Preparations